1. Home
  2. KPLT vs NEPH Comparison

KPLT vs NEPH Comparison

Compare KPLT & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Katapult Holdings Inc.

KPLT

Katapult Holdings Inc.

HOLD

Current Price

$7.36

Market Cap

52.2M

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$5.02

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPLT
NEPH
Founded
2012
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
60.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
KPLT
NEPH
Price
$7.36
$5.02
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$10.00
$6.00
AVG Volume (30 Days)
1.1M
75.2K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$280,839,000.00
$17,930,000.00
Revenue This Year
$21.42
$33.32
Revenue Next Year
$15.48
$12.27
P/E Ratio
N/A
$36.15
Revenue Growth
16.15
32.36
52 Week Low
$5.08
$1.39
52 Week High
$24.34
$6.42

Technical Indicators

Market Signals
Indicator
KPLT
NEPH
Relative Strength Index (RSI) 46.74 48.33
Support Level $6.00 $4.83
Resistance Level $7.00 $5.97
Average True Range (ATR) 0.58 0.63
MACD 0.31 -0.03
Stochastic Oscillator 35.88 28.93

Price Performance

Historical Comparison
KPLT
NEPH

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: